Pharma will have to rethink how to source, plan, manufacture and supply a growing diverse range of products in an increasingly challenging environment, drawing on resources that are much more geographically scattered – and just at a time when supply chain costs are coming under much greater pressure. The pharmaceutical supply chain is currently geared to the production of blockbusters for large populations. But, as these medicines come off patent, the economies of scale they generate will diminish.
As science is moving the industry from a ‘one size fits all’ approach to care – segmentation, personalisation and wellness – so the supply chain will need to evolve. The successful supply chain of the future is one built around flexibility, responsiveness and reliability.